Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Healthcare | Small Cap
Health Score : 7.94Jupiter Life Line Hospitals Ltd. shows strong financial health, marked by excellent profitability and an exceptionally secure balance sheet. The company has very little debt and holds substantial cash, which minimizes short-term risks. Its core operations are highly profitable and it manages its daily cash flow from sales and inventory efficiently. Key strengths are its financial stability and profit generation. However, there are areas of concern. The company has faced challenges in generating sufficient sales from its large assets like buildings and equipment. While revenue is growing, past earnings for shareholders have been very inconsistent. The company is planning significant spending on expansion, which is a future opportunity but also a risk, as it will need to generate better returns on these new investments than it has in the past.
Health Score : 7.94Jupiter Life Line Hospitals Ltd. shows strong financial health, marked by excellent profitability and an exceptionally secure balance sheet. The company has very little debt and holds substantial cash, which minimizes short-term risks. Its core operations are highly profitable and it manages its daily cash flow from sales and inventory efficiently. Key strengths are its financial stability and profit generation. However, there are areas of concern. The company has faced challenges in generating sufficient sales from its large assets like buildings and equipment. While revenue is growing, past earnings for shareholders have been very inconsistent. The company is planning significant spending on expansion, which is a future opportunity but also a risk, as it will need to generate better returns on these new investments than it has in the past.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
10.04
Industry Median
53.17
Small Cap Median
50.07
P/E RATIO
9.91
P/B RATIO
1.24
Industry Median
5.27
Small Cap Median
3.62
P/S RATIO
1.28
Industry Median
3.91
Small Cap Median
2.08
Others
PEG RATIO
0.07
EV/EBITDA RATIO
6.41
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹293.15 as on Sep 1, 2026.
Growth Score : 6.00The company's growth profile is inconsistent. It demonstrates strong and positive growth in its overall business, with both revenues and operational profits expanding at a healthy rate. This reflects successful market expansion. However, this top-line success does not consistently translate to the bottom line for shareholders. The historical growth in net income and earnings per share is extremely volatile and poor on a weighted-average basis, indicating past periods of significant underperformance that temper the otherwise positive growth story.
Revenue Growth RateExcellentOperating Profit Growth RateExcellent
Earnings Per Share (EPS) GrowthPoorAsset Growth RateExcellentNet Income Growth RatePoor| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 50.82 | 21.83 | 20.16 | 17.61 | 18.86 |
| Operating Profit Growth Rate | 128.36 | 31.37 | 20.4 | 22.73 | 15.49 |
| Earnings Per Share (EPS) Growth | 2333.33 | 28.36 | 108.84 | 9.54 | 0.27 |
| Asset Growth Rate | 15.21 | 8.47 | 29.92 | 48.71 | 25.09 |
| Net Income Growth Rate | 2650 | 43.14 | 142.47 | 9.6 | 0 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Indraprastha Medical Corporation Ltd | 8.72 | 17.86 | Neutral | 267.00 | 20.03 | 184.00 |
| 2 | Jupiter Life Line Hospitals Ltd | 7.94 | 9.91 | Highly Undervalued | 343.00 | 29.19 | 194.00 |
| 3 | Artemis Medicare Services Ltd | 7.79 | 50.07 | Overvalued | 188.00 | 6.53 | 104.00 |
| 4 | Rainbow Childrens Medicare Ltd | 5.74 | 52.79 | Neutral | 544.00 | 24.62 | 282.00 |
| 5 | Yatharth Hospital & Trauma Care Services Ltd | 4.89 | 53.56 | Neutral | 292.00 | 9.90 | 170.00 |
| 6 | Healthcare Global Enterprises Ltd | 4.53 | 765.65 | Neutral | 466.00 | 0.98 | 23.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
Quarterly Report⬤25th Jun 26
Audited Consolidated Financial Results – Q4 & FY 2025-26
UNDEFINED SENTIMENT
Concall Report⬤5th Feb 26
Q3 and 9M FY26 Earnings Conference Cal
BULLISH SENTIMENT
Jupiter Life Line Hospitals Ltd. is a leading multi-specialty tertiary and quaternary healthcare provider, primarily serving the Western India market. Operating a chain of hospitals in Thane, Pune, and Indore, the company focuses on delivering comprehensive medical, surgical, and diagnostic services across key specialities, aiming for high-quality, patient-centric care and achieving strong market positioning in its operational regions.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Jupiter Life Line Hospitals Ltd's P/E ratio (TTM) is 10.04, compared to the industry median of 53.17 and large cap median of 50.07.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Jupiter Life Line Hospitals Ltd's P/B ratio is 1.24, compared to the industry median of 5.27 and large cap median of 3.62.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Jupiter Life Line Hospitals Ltd's P/S ratio is 1.28, compared to the industry median of 3.91 and large cap median of 2.08.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Jupiter Life Line Hospitals Ltd's PEG ratio is 0.07.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Jupiter Life Line Hospitals Ltd's EV/EBITDA ratio is 6.41.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Jupiter Life Line Hospitals Ltd's ROE is 12.56%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Jupiter Life Line Hospitals Ltd's ROA is 14.39%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Jupiter Life Line Hospitals Ltd's ROCE is 15%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Jupiter Life Line Hospitals Ltd's operating margin is 22.87%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Jupiter Life Line Hospitals Ltd's net margin is 12.93%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Jupiter Life Line Hospitals Ltd's current ratio is 1.46.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Jupiter Life Line Hospitals Ltd's debt-to-equity ratio is 0.37.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Jupiter Life Line Hospitals Ltd's interest coverage ratio is 8.88.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Jupiter Life Line Hospitals Ltd's DPS is ₹0.89.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Jupiter Life Line Hospitals Ltd's EPS is 0.27.
(Source line: "Ratios as of 22 Oct 2026, based on last traded price of ₹293.15. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 2007
Headquarters: Thane, Maharashtra
Core Offerings: Oncology, Cardiology, Orthopaedics, Neurology, Gastroenterology
Stock Listing: NSE (JLHL), BSE (543980)
Promoter: Dr. Ajay Thakker & Dr. Ankit Thakker
Jupiter Life Line Hospitals Ltd. was incorporated in 2007, simultaneously establishing its flagship multi-specialty hospital in Thane, Maharashtra. The company strategically expanded its presence by commencing operations at Jupiter Hospital, Pune, in 2017, followed by Jupiter Hospital, Indore, in 2021. This expansion cemented its position as a significant healthcare player in Western India. In September 2023, the company successfully completed its Initial Public Offering (IPO) and listed on the NSE and BSE, marking a key milestone in its growth trajectory.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Hospital Services | 100% | Operating Profit |
Multi-Specialty Tertiary & Quaternary Care: Operates a network of hospitals with over 1,000 beds across Thane, Pune, and Indore, offering advanced medical and surgical interventions in critical and complex conditions.
Comprehensive Clinical Services: Provides a broad spectrum of medical services encompassing high-demand specialities like cardiology, orthopaedics, oncology, neurology, gastroenterology, and critical care.
Advanced Infrastructure: Utilizes state-of-the-art medical technology and infrastructure to support complex procedures and enhance patient outcomes across its facilities.
Patient-Centric Approach: Focuses on delivering personalized and ethical healthcare services, emphasizing quality of care and patient satisfaction.
Dr. Ajay Thakker: Chairman & Managing Director. A visionary medical professional and entrepreneur, he is the founder of Jupiter Life Line Hospitals and has been instrumental in its strategic growth and operational excellence.
Jupiter Healthcare Private Limited
Medizone Healthcare Private Limited
Juno Life Line Hospitals Private Limited
September 2023: Initial Public Offering (IPO) of 1,18,04,260 equity shares, raising ₹869.08 crores.
The Jupiter Life Line Hospitals Ltd share price today is ₹293.15 on NSE (JLHL), as of 23 Oct 2026.
As of 22 Oct 2026, Jupiter Life Line Hospitals Ltd share price is ₹293.15, with previous close ₹293.15. Today's range is ₹293.15 to ₹293.15. The 52-week range is ₹233.40 to ₹1582.90.
As of today, Jupiter Life Line Hospitals Ltd's market cap is ₹1,923.06 crore (Small Cap).
Jupiter Life Line Hospitals Ltd's current P/E ratio is 10.04, compared to the DIVERSIFIED CONSUMER SERVICES sector average of 50.
Jupiter Life Line Hospitals Ltd's current P/B ratio is 1.24.
Jupiter Life Line Hospitals Ltd's current dividend yield is 0.30%. Last dividend of ₹0.00 per share was declared on N/A.
Jupiter Life Line Hospitals Ltd's EPS (TTM) is ₹0.27.
Jupiter Life Line Hospitals Ltd. is a leading multi-specialty tertiary and quaternary healthcare provider, primarily serving the Western India market. Operating a chain of hospitals in Thane, Pune, and Indore, the company focuses on delivering comprehensive medical, surgical, and diagnostic services across key specialities, aiming for high-quality, patient-centric care and achieving strong market positioning in its operational regions.
Jupiter Life Line Hospitals Ltd is promoted by Dr. Ajay Thakker & Dr. Ankit Thakker, holding 40.91% as of 22 Oct 2026.
Jupiter Life Line Hospitals Ltd is listed on NSE (JLHL) and BSE (543980). Its next quarterly results are expected on August 2024 (Q1 FY25).
Accounting quality red flags
